A half century after Prozac, a new generation of depression drugs is bringing hope to a long-stagnant field
New drugs for depression and new thinking are now transforming a field that has long been stagnant, paving the way for more precise, individualized treatments.
This article is excerpted from the latest STAT Report: Treating Depression: a new era of promising Drugs.
On May 8, 1972, a researcher at Eli Lilly in Indianapolis named Jong-Sin Horng tested a compound his team had developed and found it had a curious property.
What's Your Reaction?
